Table of contents

Inflammation and inflammatory bowel disease

• Interleukin 2 modulates ion secretion and cell proliferation in cultured human small intestinal enterocytes (1 November, 2001) Free

  E V O'Loughlin, G P Pang, R Noltorp, C Koina, R Batey, R Clancy
• Allelic variation at the interleukin 1β gene is associated with decreased bone mass in patients with inflammatory bowel diseases (1 November, 2001) Free

  A Nemetz, M Tóth, M A García-González, T Zágoni, J Fehér, A S Peña, Z Tulassay
• Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs (1 November, 2001) Free

  E Smecuol, J C Bai, E Sugai, H Vazquez, S Niveloni, S Pedreira, E Mauriño, J Meddings
• Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide (1 November, 2001) Free

  P W Lowry, C L Franklin, A L Weaver, C L Szumlanski, D C Mays, E V Loftus, W J Tremaine, J J Lipsky, R M Weinshilboum, W J Sandborn
• Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease (1 November, 2001) Free

  P W Lowry, C L Franklin, A L Weaver, M Gennett Pike, D C Mays, W J Tremaine, J J Lipsky, W J Sandborn
• High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis (1 November, 2001) Free

  P R Fleshner, E A Vasiliauskas, L Y Kam, N E Fleshner, J Gaiennie, M T Abreu-Martin, S R Targan